Nancy Carpenter

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study

Michael D. Tarantino, James B. Bussel, Victor S. Blanchette et al. · The Lancet · 2016 · 155 citations

Medicine, Hematology, Immunology +9

VISUAL AND NEUROLOGICAL OUTCOME OF INFANTS WITH PERIVENTRICULAR LEUKOMALACIA

Mark S. Scher, Velma Dobson, Nancy Carpenter et al. · Developmental Medicine & Child Neurology · 1989 · 102 citations

Medicine, Neurology, Pediatrics +17

Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial

Hagop M. Kantarjian, Pierre Fenaux, Mikkael A. Sekeres et al. · The Lancet Haematology · 2018 · 101 citations

Medicine, Hematology, Pharmacology +10

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

Douglas B. Cines, Jeffrey S. Wasser, Francesco Rodeghiero et al. · Haematologica · 2017 · 64 citations · Full text

Medicine, Hematology, Pharmacology +14

A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Effect of Romiplostim on Health‐Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents

Susan D. Mathias, Xiaoyan Li, Melissa Eisen et al. · Pediatric Blood & Cancer · 2016 · 48 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +13